ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Seer Inc

Seer Inc (SEER)

2.26
0.02
(0.89%)
Closed 13 November 8:00AM
2.2201
-0.0399
(-1.77%)
After Hours: 9:44AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.2201
Bid
2.22
Offer
2.39
Volume
263,629
2.18 Day's Range 2.28
1.455 52 Week Range 2.4599
Market Cap
Previous Close
2.24
Open
2.20
Last Trade
50
@
2.22
Last Trade Time
Financial Volume
US$ 588,524
VWAP
2.2324
Average Volume (3m)
289,100
Shares Outstanding
58,966,560
Dividend Yield
-
PE Ratio
-1.54
Earnings Per Share (EPS)
-1.46
Revenue
16.66M
Net Profit
-86.28M

About Seer Inc

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Seer Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker SEER. The last closing price for Seer was US$2.24. Over the last year, Seer shares have traded in a share price range of US$ 1.455 to US$ 2.4599.

Seer currently has 58,966,560 shares in issue. The market capitalisation of Seer is US$132.09 million. Seer has a price to earnings ratio (PE ratio) of -1.54.

SEER Latest News

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...

Seer Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported...

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the...

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements...

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

REDWOOD CITY, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.210110.45273631842.012.459924316542.21751949CS
40.240112.12626262631.982.45991.822189112.07314481CS
120.570134.55151515151.652.45991.5852891001.84492948CS
260.220111.00522.45991.564271611.81476667CS
520.640140.51265822781.582.45991.4554554851.80819936CS
156-27.1199-92.433197000729.3431.83151.4553966936.26816914CS
260-45.7799-95.37479166674886.551.45541861216.82388339CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTCTBTC Digital Ltd
US$ 10.50
(316.67%)
127.83M
NANano Labs Ltd
US$ 8.03
(144.07%)
1.49M
NXTTNext Technology Holding Inc
US$ 2.0374
(77.16%)
5.58M
MULNMullen Automotive Inc
US$ 2.95
(72.51%)
65.66M
PAMTPAMT Corporation
 21.54
(70.82%)
68.88k
ACABAtlantic Coastal Acquisition Corporation II
US$ 5.77
(-47.06%)
162.49k
NGNENeurogene Inc
US$ 39.875
(-44.25%)
1.99M
RMTIRockwell Medical Inc
US$ 2.84
(-38.92%)
6.48M
PROCProcaps Group SA
US$ 0.97
(-37.33%)
101k
STIMNeuronetics Inc
US$ 0.6999
(-36.37%)
7.77M
CEROCERo Therapeutics Holdings Inc
US$ 0.2711
(38.32%)
765.03M
LGMKLogicMark Inc
US$ 0.184
(38.35%)
546.57M
NVDANVIDIA Corporation
US$ 148.29
(2.09%)
196.62M
LIFWMSP Recovery Inc
US$ 0.1144
(-9.71%)
169.35M
TSLATesla Inc
US$ 328.49
(-6.15%)
154.09M

Discussion

View Full Feed
No Posts Found